Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	1.299
Companies that carry out R&D in Biotechnology	Main	559
Companies that carry out R&D in Biotechnology	Secondary dwellings	230
Companies that carry out R&D in Biotechnology	Tool	510
%Companies according to biotechnology used: Genetic code	Total	30,8
%Companies according to biotechnology used: Genetic code	Main	39,2
%Companies according to biotechnology used: Genetic code	Secondary dwellings	31,4
%Companies according to biotechnology used: Genetic code	Tool	21,3
%Companies according to biotechnology used: Functional units	Total	38,4
%Companies according to biotechnology used: Functional units	Main	45,7
%Companies according to biotechnology used: Functional units	Secondary dwellings	43
%Companies according to biotechnology used: Functional units	Tool	28,3
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	21,5
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	26,3
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	19,8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	17,1
%Companies according to biotechnology used: Bioprocesses	Total	50,8
%Companies according to biotechnology used: Bioprocesses	Main	40,7
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	54,3
%Companies according to biotechnology used: Bioprocesses	Tool	60,2
%Companies according to biotechnology used: Sub-cellular organisms	Total	8,5
%Companies according to biotechnology used: Sub-cellular organisms	Main	12,7
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	4,6
%Companies according to biotechnology used: Sub-cellular organisms	Tool	5,6
%Companies according to biotechnology used: Bio-computing	Total	24
%Companies according to biotechnology used: Bio-computing	Main	34,7
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	22,1
%Companies according to biotechnology used: Bio-computing	Tool	13,2
%Companies according to biotechnology used: Nanobiotechnology	Total	12,1
%Companies according to biotechnology used: Nanobiotechnology	Main	15,6
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	15,6
%Companies according to biotechnology used: Nanobiotechnology	Tool	6,6
%Companies according to biotechnology used: Other	Total	16,9
%Companies according to biotechnology used: Other	Main	19,2
%Companies according to biotechnology used: Other	Secondary dwellings	20,6
%Companies according to biotechnology used: Other	Tool	12,7
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	45,5
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	64,2
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	36,9
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	28,8
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	15,5
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	17,4
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	16
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	13,1
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	32,3
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	21
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	34,5
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	43,8
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	23,8
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	20,7
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	30,9
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	23,9
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	15,6
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	14,1
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	24
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	13,5
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	13,7
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	14,7
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	18,5
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	10,6
Personnel in R&D in biotechnology (no. of persons)	Total	15.750
Personnel in R&D in biotechnology (no. of persons)	Main	6.759
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	3.644
Personnel in R&D in biotechnology (no. of persons)	Tool	5.347
Personnel in R&D in biotechnology (no. of persons): Research personnel	Total	8.379
Personnel in R&D in biotechnology (no. of persons): Research personnel	Main	3.802
Personnel in R&D in biotechnology (no. of persons): Research personnel	Secondary dwellings	2.145
Personnel in R&D in biotechnology (no. of persons): Research personnel	Tool	2.433
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel	Total	7.371
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel	Main	2.957
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel	Secondary dwellings	1.500
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel	Tool	2.914
Personnel in R&D in biotechnology (no. of persons). Women	Total	8.711
Personnel in R&D in biotechnology (no. of persons). Women	Main	3.890
Personnel in R&D in biotechnology (no. of persons). Women	Secondary dwellings	2.040
Personnel in R&D in biotechnology (no. of persons). Women	Tool	2.782
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel	Total	4.510
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel	Main	2.078
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel	Secondary dwellings	1.196
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel	Tool	1.236
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel	Total	4.200
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel	Main	1.811
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel	Secondary dwellings	843
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel	Tool	1.546
Personnel in R&D in biotechnology (FTE)	Total	11.528,6
Personnel in R&D in biotechnology (FTE)	Main	5.389
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	2.417,3
Personnel in R&D in biotechnology (FTE)	Tool	3.722,4
Personnel in R&D in biotechnology (FTE): Research personnel	Total	6.342,7
Personnel in R&D in biotechnology (FTE): Research personnel	Main	3.157
Personnel in R&D in biotechnology (FTE): Research personnel	Secondary dwellings	1.493,6
Personnel in R&D in biotechnology (FTE): Research personnel	Tool	1.692,1
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel	Total	5.185,9
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel	Main	2.232
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel	Secondary dwellings	923,7
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel	Tool	2.030,3
Personnel in R&D in biotechnology (FTE). Women	Total	6.539,7
Personnel in R&D in biotechnology (FTE). Women	Main	3.168,1
Personnel in R&D in biotechnology (FTE). Women	Secondary dwellings	1.378,1
Personnel in R&D in biotechnology (FTE). Women	Tool	1.993,6
Personnel in R&D in biotechnology (FTE). Women: Research personnel	Total	3.455,7
Personnel in R&D in biotechnology (FTE). Women: Research personnel	Main	1.734,1
Personnel in R&D in biotechnology (FTE). Women: Research personnel	Secondary dwellings	839,4
Personnel in R&D in biotechnology (FTE). Women: Research personnel	Tool	882,2
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel	Total	3.084
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel	Main	1.434
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel	Secondary dwellings	538,7
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel	Tool	1.111,4
Internal expenditure on R&D (thousands of euros)	Total	1.038.582
Internal expenditure on R&D (thousands of euros)	Main	519.104
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	204.849
Internal expenditure on R&D (thousands of euros)	Tool	314.630
1) By nature of the expense: Current expenses	Total	940.091
1) By nature of the expense: Current expenses	Main	466.051
1) By nature of the expense: Current expenses	Secondary dwellings	179.259
1) By nature of the expense: Current expenses	Tool	294.780
1.1) Remuneration to research personnel	Total	321.570
1.1) Remuneration to research personnel	Main	164.629
1.1) Remuneration to research personnel	Secondary dwellings	73.301
1.1) Remuneration to research personnel	Tool	83.640
1.2) Remuneration to technicians and auxiliary personnel	Total	194.836
1.2) Remuneration to technicians and auxiliary personnel	Main	85.747
1.2) Remuneration to technicians and auxiliary personnel	Secondary dwellings	33.173
1.2) Remuneration to technicians and auxiliary personnel	Tool	75.916
1.3) Other current expenses	Total	423.685
1.3) Other current expenses	Main	215.675
1.3) Other current expenses	Secondary dwellings	72.786
1.3) Other current expenses	Tool	135.225
2) By nature of the expense: Capital expenses	Total	98.492
2) By nature of the expense: Capital expenses	Main	53.052
2) By nature of the expense: Capital expenses	Secondary dwellings	25.589
2) By nature of the expense: Capital expenses	Tool	19.850
2.1) Land and buildings	Total	10.199
2.1) Land and buildings	Main	5.434
2.1) Land and buildings	Secondary dwellings	2.616
2.1) Land and buildings	Tool	2.149
2.2) Equipment and instruments	Total	72.584
2.2) Equipment and instruments	Main	36.725
2.2) Equipment and instruments	Secondary dwellings	20.086
2.2) Equipment and instruments	Tool	15.773
2.3) Acquisition of specific R+D software	Total	5.721
2.3) Acquisition of specific R+D software	Main	2.513
2.3) Acquisition of specific R+D software	Secondary dwellings	2.103
2.3) Acquisition of specific R+D software	Tool	1.104
2.4) Otros productos de propiedad intelectual específicos para I+D	Total	9.987
2.4) Otros productos de propiedad intelectual específicos para I+D	Main	8.379
2.4) Otros productos de propiedad intelectual específicos para I+D	Secondary dwellings	784
2.4) Otros productos de propiedad intelectual específicos para I+D	Tool	823
1.1) By origin of the funds: Own funds	Total	711.488
1.1) By origin of the funds: Own funds	Main	314.308
1.1) By origin of the funds: Own funds	Secondary dwellings	155.688
1.1) By origin of the funds: Own funds	Tool	241.492
1.2) By origin of the funds: From companies	Total	121.738
1.2) By origin of the funds: From companies	Main	80.154
1.2) By origin of the funds: From companies	Secondary dwellings	10.983
1.2) By origin of the funds: From companies	Tool	30.601
1.3) By origin of the funds: Public Administration funds	Total	107.477
1.3) By origin of the funds: Public Administration funds	Main	61.083
1.3) By origin of the funds: Public Administration funds	Secondary dwellings	16.108
1.3) By origin of the funds: Public Administration funds	Tool	30.285
1.4) By origin of the funds: From Universities	Total	192
1.4) By origin of the funds: From Universities	Main	68
1.4) By origin of the funds: From Universities	Secondary dwellings	14
1.4) By origin of the funds: From Universities	Tool	111
1.5) By origin of the funds: From non profit private institutions	Total	10.756
1.5) By origin of the funds: From non profit private institutions	Main	9.444
1.5) By origin of the funds: From non profit private institutions	Secondary dwellings	0
1.5) By origin of the funds: From non profit private institutions	Tool	1.312
1.6) By origin of the funds: Foreign funds	Total	86.931
1.6) By origin of the funds: Foreign funds	Main	54.046
1.6) By origin of the funds: Foreign funds	Secondary dwellings	22.055
1.6) By origin of the funds: Foreign funds	Tool	10.829
Purchase of R&D services in biotechnology (thousands of euros)	Total	145.557
Purchase of R&D services in biotechnology (thousands of euros)	Main	105.405
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	16.127
Purchase of R&D services in biotechnology (thousands of euros)	Tool	24.025
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	95.915
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	74.486
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	14.004
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	7.425
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	49.642
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	30.919
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	2.123
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	16.600
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	40,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	49,4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	39,8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	30,4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	13,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	12,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	15,9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	12,7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	19
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	21,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	20
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	15,7
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	11,5
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	10,4
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	15,1
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	11,1
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets	Total	15,9
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets	Main	16,1
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets	Secondary dwellings	23,5
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets	Tool	12,1
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels	Total	17
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels	Main	20,6
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels	Secondary dwellings	19,3
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels	Tool	11,9
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception	Total	16,4
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception	Main	16,3
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception	Secondary dwellings	23,1
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception	Tool	13,6
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	40,5
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	46,9
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	44,1
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	31,9
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost	Total	55
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost	Main	65,2
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost	Secondary dwellings	55,1
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost	Tool	43,8
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	21,9
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	24,5
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	25
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	17,6
% Companies with income of an international origin related to biotechnological activities	Total	23,5
% Companies with income of an international origin related to biotechnological activities	Main	33,3
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	19,8
% Companies with income of an international origin related to biotechnological activities	Tool	14,4
% Turnover representing income of an international origin related to biotechnological activities	Total	1,9
% Turnover representing income of an international origin related to biotechnological activities	Main	12,1
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	1,2
% Turnover representing income of an international origin related to biotechnological activities	Tool	1,3
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	61,6
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	44
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	79,9
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	60,4
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	38,4
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	56
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	20,1
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	39,6
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	87,6
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	97
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	73,4
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	96,5
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	10,9
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	1,5
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	25,9
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	0,9
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	1,1
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	1,3
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	0,7
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	1,3
% Income of an international origin related with activities according to the classification: Other	Total	0,4
% Income of an international origin related with activities according to the classification: Other	Main	0,2
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	0
% Income of an international origin related with activities according to the classification: Other	Tool	1,3